Bioinformatics Core
生物信息学核心
基本信息
- 批准号:10576204
- 负责人:
- 金额:$ 19.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-14 至 2023-07-13
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdoptionAwardBasic ScienceBioinformaticsBiological SciencesBiologyBiomedical ResearchBiotechnologyBusinessesCaliberCenters of Research ExcellenceClinical SciencesCollaborationsCommunicable DiseasesCommunitiesCommunity of PracticeCore FacilityCustomDataData AnalysesDatabasesDevelopmentDisciplineDiseaseEducational workshopEffectivenessEmerging Communicable DiseasesEnsureEpigenetic ProcessEquilibriumExtramural ActivitiesFacultyFosteringFundingFunding AgencyGenerationsGeneticGenomicsGrowthHawaiiHealthHospitalsHumanInfectious Diseases ResearchInformation TechnologyInfrastructureInstitutionInstitutionalizationKnowledgeLettersMarketingMedicineMethodsMissionNeeds AssessmentOccupationsPerformancePhasePlayPositioning AttributePreventivePrivatizationProceduresProcessRapid diagnosticsResearchResearch PersonnelResourcesRiskRoleScienceScientific InquiryServicesSourceStrategic PlanningStreamSurveysSystemTechniquesTechnologyTimeTrainingTraining and EducationTranslational ResearchUniversitiesVaccinesWorkbasebig-data sciencebioinformatics infrastructurebioinformatics resourcebioinformatics toolbiological researchcohesioncomplex biological systemscomputing resourcescyber infrastructuredesignempoweredimprovednext generation sequencingoperationoutreachpersonalized predictionspreventprogramssatisfactionsuccesstherapeutically effectivetooluser-friendlyweb portal
项目摘要
Project Summary for the Bioinformatics Core
Explosive growth in powerful bioinformatics tools and continued refinements in well-annotated databases have
accelerated the acquisition of new knowledge about the myriad genetic and epigenetic determinants of
infectious diseases and other diseases that cause untold human suffering. In this regard, big-data science
holds the promise for personalized, predictive, preventive and participatory medicine to improve human health
and prevent disease. Thus, the importance of sustaining the Bioinformatics Core cannot be overstated. During
COBRE Phase II, the Bioinformatics Core placed a major emphasis on providing customized support and
collaborative services, on developing new and improved bioinformatics tools, and on conducting intensive
educational courses and hands-on training workshops.
The Phase III COBRE objective of facilitating the transition of the Bioinformatics Core into a sustainable state-
of-the-art core facility capable of supporting high-caliber research on new, emerging and re-emerging
infectious diseases, as well as other fields of scientific inquiry, will be achieved by (1) enhancing and
streamlining core operations; (2) growing and diversifying the user base, capability, capacity and reach; and
(3) strengthening the core infrastructure. For Aim 1, needs assessments and user satisfaction surveys will be
conducted to ensure efficiency and effectiveness of core operations at the core/user interface and user
services. For Aim 2, outreach and marketing activities will be expanded to other local academic institutions,
biotech companies and hospitals beyond the UH System, and strong partnerships will be formed with similar
cores located in other COBRE, INBRE and IDeA-CTR programs to further grow and diversify the core user
base and to acquire new tools and techniques. And for Aim 3, institutionalization and phased-in business plans
will be developed during the Phase III COBRE to draw on intramural and extramural sources for sustainability.
It is envisioned that the Bioinformatics Core will achieve each of the above-stated specific aims. A strong
commitment by the President of the UH System to fully support the Bioinformatics Core infrastructure, with
professional positions and support staff, within the next five years is part of a larger strategic plan to
institutionalize bioinformatics as one of the four principal pillars in the Division of Cyberinfrastructure. Thus,
there is every reason to be optimistic that the Bioinformatics Core will be transformed into a system-wide
bioinformatics resource to confront the challenges of big-data science.
生物信息学核心的项目总结
强大的生物信息学工具的爆炸性增长和注释良好的数据库的持续完善
加速获得关于多种遗传和表观遗传决定因素的新知识
传染病和其他给人类带来难以形容的痛苦的疾病。在这方面,大数据科学
拥有改善人类健康的个性化、预测性、预防性和参与性医学的前景
并预防疾病。因此,维持生物信息学核心的重要性怎么强调都不为过。在.期间
在Cobre第二阶段,生物信息学核心主要强调提供定制的支持和
协作服务,开发新的和改进的生物信息学工具,并进行密集
教育课程和实践培训讲习班。
Cobre第三阶段的目标是促进生物信息学核心向可持续状态的转变-
最先进的核心设施,能够支持对新的、新兴的和重新出现的高水平研究
传染病以及其他科学研究领域将通过以下方式实现:(1)加强和
精简核心业务;(2)扩大和多样化用户基础、能力、能力和覆盖范围;以及
(三)强化核心基础设施。对于目标1,将进行需求评估和用户满意度调查
为确保核心/用户界面和用户的核心操作的效率和效力而进行
服务。对于目标2,外联和营销活动将扩大到其他地方学术机构,
UH系统之外的生物技术公司和医院,并将与类似的
位于其他Cobre、INBRE和IDEA-CTR计划中的核心,以进一步增长核心用户并使其多样化
建立基础,并获得新的工具和技术。对于目标3,制度化和分阶段实施业务计划
将在第三阶段眼镜蛇期间开发,以利用可持续发展的墙内和墙外来源。
预计生物信息学核心将实现上述每一个具体目标。一个坚强的人
UH系统总裁承诺全力支持生物信息学核心基础设施,
专业职位和支助人员,是未来五年更大战略计划的一部分
使生物信息学制度化,将其作为数字基础设施司的四大支柱之一。因此,
我们完全有理由乐观地认为,生物信息学核心将转变为全系统的
生物信息学资源以应对大数据科学的挑战。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Youping Deng其他文献
Youping Deng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Youping Deng', 18)}}的其他基金
The Hawaii Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN)
夏威夷精准营养科学研究人工智能高级培训 (AIPRN)
- 批准号:
10752542 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Characterizing genomic risk factors of lung cancers in Native Hawaiians
夏威夷原住民肺癌基因组风险因素的特征
- 批准号:
10749847 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms
循环脂质和 miRNA 标记物用于乳房 X 光检查异常女性乳腺癌的早期检测
- 批准号:
10459379 - 财政年份:2019
- 资助金额:
$ 19.35万 - 项目类别:
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms
循环脂质和 miRNA 标记物用于乳房 X 光检查异常女性乳腺癌的早期检测
- 批准号:
10673061 - 财政年份:2019
- 资助金额:
$ 19.35万 - 项目类别:
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms
循环脂质和 miRNA 标记物用于乳房 X 光检查异常女性乳腺癌的早期检测
- 批准号:
9982252 - 财政年份:2019
- 资助金额:
$ 19.35万 - 项目类别:
Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms
循环脂质和 miRNA 标记物用于乳房 X 光检查异常女性乳腺癌的早期检测
- 批准号:
10218097 - 财政年份:2019
- 资助金额:
$ 19.35万 - 项目类别:
Profiling genome-wide circulating ncRNAs for the early detection of lung cancer
分析全基因组循环 ncRNA 以早期检测肺癌
- 批准号:
10477044 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
Profiling genome-wide circulating ncRNAs for the early detection of lung cancer
分析全基因组循环 ncRNA 以早期检测肺癌
- 批准号:
10242187 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
Profiling genome-wide circulating ncRNAs for the early detection of lung cancer
分析全基因组循环 ncRNA 以早期检测肺癌
- 批准号:
10000889 - 财政年份:2018
- 资助金额:
$ 19.35万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.35万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 19.35万 - 项目类别:
Standard Grant














{{item.name}}会员




